This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2016 Mar;69(3):540.

doi: 10.1016/j.eururo.2015.12.027.

Words of Wisdom. Re: Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

Declan G Murphy¹, Homayoun Zargar²

Affiliations

Affiliations

¹ Division of Cancer Surgery, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia; Epworth Prostate Centre, Epworth Healthcare, Richmond, Australia; Department of Urology, Royal Melbourne Hospital, Melbourne, Australia. Electronic address: declan.murphy@petermac.org.
² Department of Urology, Royal Melbourne Hospital, Melbourne, Australia.

PMID: 26867727
DOI: 10.1016/j.eururo.2015.12.027

Comment

Words of Wisdom. Re: Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

Declan G Murphy et al. Eur Urol. 2016 Mar.

. 2016 Mar;69(3):540.

doi: 10.1016/j.eururo.2015.12.027.

Authors

Declan G Murphy¹, Homayoun Zargar²

Affiliations

¹ Division of Cancer Surgery, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia; Epworth Prostate Centre, Epworth Healthcare, Richmond, Australia; Department of Urology, Royal Melbourne Hospital, Melbourne, Australia. Electronic address: declan.murphy@petermac.org.
² Department of Urology, Royal Melbourne Hospital, Melbourne, Australia.

PMID: 26867727
DOI: 10.1016/j.eururo.2015.12.027

No abstract available

PubMed Disclaimer

Comment on

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer.
Sweeney CJ, Chen YH, Carducci M, Liu G, Jarrard DF, Eisenberger M, Wong YN, Hahn N, Kohli M, Cooney MM, Dreicer R, Vogelzang NJ, Picus J, Shevrin D, Hussain M, Garcia JA, DiPaola RS. Sweeney CJ, et al. N Engl J Med. 2015 Aug 20;373(8):737-46. doi: 10.1056/NEJMoa1503747. Epub 2015 Aug 5. N Engl J Med. 2015. PMID: 26244877 Free PMC article. Clinical Trial.

Similar articles

Words of Wisdom. Re: Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer.
Mathieu R, Shariat SF. Mathieu R, et al. Eur Urol. 2016 Apr;69(4):755-6. doi: 10.1016/j.eururo.2016.01.020. Epub 2016 Feb 18. Eur Urol. 2016. PMID: 26972499 No abstract available.
Re: Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer.
Taneja SS. Taneja SS. J Urol. 2016 Jan;195(1):94. doi: 10.1016/j.juro.2015.10.055. Epub 2015 Oct 23. J Urol. 2016. PMID: 26699961 No abstract available.
Chemohormonal Therapy in Hormone-Sensitive Prostate Cancer.
Ciccarese C, Santoni M, Massari F. Ciccarese C, et al. N Engl J Med. 2016 Jan 21;374(3):286. doi: 10.1056/NEJMc1511800. N Engl J Med. 2016. PMID: 26789884 No abstract available.
Chemohormonal therapy for metastatic hormone-sensitive prostate cancer: An Asian perspective.
Teoh JY, Ng CF, Poon DM. Teoh JY, et al. Asia Pac J Clin Oncol. 2018 Nov;14 Suppl 5:5-8. doi: 10.1111/ajco.13060. Asia Pac J Clin Oncol. 2018. PMID: 30489034 Review.
[Taxanes in the chemotherapy of hormone-refractory prostate carcinoma].
Johannsen M, Wilke K, Schnorr D, Loening SA. Johannsen M, et al. Urologe A. 2004 Feb;43(2):160-7. doi: 10.1007/s00120-004-0528-3. Urologe A. 2004. PMID: 14991117 Review. German.

See all similar articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information